The Robert A. Winn Diversity in Clinical Trials Award Program Established by the Bristol Myers Squibb Foundation To Expand With Amgen’s Commitment of $8 Million
The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Award Program) established by the Bristol Myers Squibb Foundation (BMSF) announced that Amgen, a global biotechnology company, has committed to contribute $8 million over the next four years.
Biking the Globe for C2C4C
A handful of inspirational words from author Scott Stoll served as the rallying cry for more than 350 Bristol Myers Squibb employees representing 23 nations who successfully trained and participated in four regional bicycle rides collectively known as C2C4C.
Moments of Serendipity As Our Teams 'Light the Night'
The experience was “miraculous” for Asalia, and this story is one of countless from the annual walks that support the Leukemia and Lymphoma Society (LLS), with which Bristol Myers Squibb has had a long-standing partnership.
Cancer Care Milestone Reached in Lesotho
For too many years, cancer patients in Lesotho felt life-changing cancer treatment was out of reach. No oncology clinics existed in their landlocked country ringed by steep mountains and surrounded by South Africa.
Empowering Psoriasis Patients Through Mental Health Support
This year, in recognition of World Psoriasis Day on October 29, we’re focusing on the mental health challenges that people living with psoriatic disease face as a result of their illness.
Dreaming Big and Trusting in Talent: Getting To Know John Loveseth
Meet John Loveseth, the global lead for CLIMB (Cultivating Leadership in Millennials and Beyond), one of our eight People & Business Resource Groups (PBRGs) at Bristol Myers Squibb.
Scientific and Hiking Adventures To Inspire the Next Generation of Researchers
From backpacking through the California mountains with a renowned physician-scientist to developing a hypothesis, collecting, analyzing and presenting data, the R&D internship program prioritizes recruiting interns from diverse backgrounds.
From Patient to Physician: Trading Places
"Why am I so passionate about making patients a No. 1 priority? In part, it’s because at an early age I had an experience as a patient myself that made a big impression on me."
Exploring Pathways in Immune-Mediated Diseases To Advance Patient Care
The idea of using one drug to treat many diseases is not entirely new. Historically, therapeutics like immunosuppressants or steroids have been used broadly across many immune-mediated diseases.
Using the Power of Technology To Better Serve Our Patients
It's inevitable: Thanks to technology, we are going to see true breakthroughs in finding powerful medicines, and in treating, diagnosing and, hopefully, curing diseases.